Search Results 1861-1870 of 14762 for anti-TNF drugs

  1. Stopping Versus Continuation of Long-term Mepolizumab in Severe Eosinophilic Asthma Patients - Mayo Clinic

    ... treatment gaps of more than 12 weeks [84 days] between any two doses). Current Anti-Asthma Therapy: Asthma is currently being treated with a controller ...

  2. Clinical Trials - Division of Infectious Diseases - Mayo Clinic Research

    The purpose of the study is to determine the extent of donor site morbidity after harvesting the medial femoral condyle for scaphoid nonunion treatment. The ...

  3. Efficacy of Riluzole in Surgical Treatment for Cervical Spondylotic Myelopathy (CSM-Protect) - Mayo Clinic

    About this study. CSM (Cervical spondylotic myelopathy) is the most common cause of spinal cord injury worldwide. While there is evidence from the recently ...

  4. Dabrafenib in Treating Patients With Solid Tumors and Kidney or Liver Dysfunction - Mayo Clinic

    Use of an investigational anti-cancer drug within 28 days preceding the first dose of dabrafenib; Patients receiving any medications or substances that are ...

  5. Ophthalmology News - Medical Professionals - Mayo Clinic

    Intravitreal anti-VEGF pharmacotherapy safe for treatment of diabetic macular edema. Study offers further evidence of a relatively safe systemic risk profile ...

  6. Influenza Virus Vaccine (Intradermal Route, Intramuscular Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. In 1976, a number of people who received the “swine flu” influenza vaccine developed ...

  7. TRC-PAD Program: In-Clinic Trial-Ready Cohort - Mayo Clinic

    Treatment with another anti-amyloid investigational drug or other intervention within 12 months. Enrolled in another interventional clinical trial within ...

  8. Talc (Intrapleural Route) Description and Brand Names - Mayo Clinic

    Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Sclerosol Intrapleural; Steritalc. Descriptions.

  9. A Study Evaluating the Efficacy and Safety of Obinutuzumab in Participants With Primary Membranous Nephropathy - Mayo Clinic

    Any major episode of infection requiring hospitalization or treatment either with IV anti-infective treatments during the 2 months prior to or during ...

  10. Rituximab-Pvvr (Intravenous Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...